Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast

Vaccine

Volumn 18, Issue 14, 2000, Pages 1402-1411

  Milek, Richard L B ^a   Stunnenberg, Hendrik G ^a   Konings, Ruud N H ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Pfs48 45; Plasmodium falciparum; Yeast

Indexed keywords

ANTIGEN; BLOCKING ANTIBODY; DISULFIDE; EPITOPE; MALARIA VACCINE; RECOMBINANT VACCINE; SYNTHETIC DNA;

ARTICLE; GENE EXPRESSION; GENE SEQUENCE; NONHUMAN; NORTHERN BLOTTING; PICHIA PASTORIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RECOMBINANT DNA TECHNOLOGY; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION TERMINATION; VACCINE PRODUCTION; YEAST;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA, PROTOZOAN; GENES, SYNTHETIC; HUMANS; MALARIA; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PICHIA; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SACCHAROMYCES CEREVISIAE; TRANSFECTION;

EID: 0033966840     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00392-8     Document Type: Article

References (46)

1. Vermeulen A.N., van Deursen J., Brakenhoff R.H., Lensen T.H.W., Ponnudurai T., Meeuwissen J.H.E.T. Characterization of Plasmodium falciparum sexual stage antigens and their biosynthesis in synchronised gametocyte cultures. Mol. Biochem. Parasitol. 20:1986;155-163.
2. Ong C.S.L., Zhang K.Y., Eida S.J., Graves P.M., Dow C., Looker M., Rogers N.C., Chiodini P.L., Targett G.A.T. The primary antibody response of malaria patients to Plasmodium falciparum transmission blocking vaccine candidates. Par. Imm. 12:1990;447-456.
3. Riley E.M., Ong C.S.L., Olerup O., Eida S., Allen S.J., Bennet S., Andersson G., Targett G.A.T. Cellular and humoral immune responses to Plasmodium falciparum gametocyte antigens in malaria-immune individuals. J. Immunol. 144:1990;4810-4816.
4. Roeffen W., Mulder B., Teelen K., Bolmer M., Eling W., Targett G.A.T., Beckers P.J.A., Sauerwein R. Association between anti-Pfs48/45 reactivity and Plasmodium falciparum transmission-blocking activity in sera from Cameroon. Par. Immunol. 18:1996;103-109.
5. Kaslow D.C. Transmission-blocking vaccines: uses and current status of development. Int. J. Par. 27:1997;183-189.
6. Lobo C.A., Dhar R., Kumar N. Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies. Inf. Immun. 67:1999;1688-1693.
7. Kocken C.H.M., Milek R.L.B., Lensen T.H.W., Kaslow D.C., Schoenmakers J.G.G., Konings R.N.H. Minimal variation in the transmission-blocking vaccine candidate Pfs48/45 of the human malaria parasite Plasmodium falciparum. Mol. Biochem. Par. 69:1995;115-118.
8. Kocken C.H.M., Jansen J., Kaan A.M., Beckers P.J.A., Ponnudurai T., Kaslow D.C., Konings R.N.H., Schoenmakers J.G.G. Cloning and expression of the gene coding for the transmission-blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol. Biochem. Par. 61:1993;59-68.
9. Carter R., Graves P.M., Keister D.B., Quakyi I.A. Properties of epitopes of Pfs48/45, a target of transmission-blocking monoclonal antibodies, on gametes of different isolates of Plasmodium falciparum. Par. Imm. 12:1990;587-603.
10. Targett G.A., Harte P.G., Eida S., Rogers N.C., Ong C.S. Plasmodium falciparum sexual stage antigens: immunogenicity and cell-mediated responses. Immunol. Let. 25:1990;77-81.
11. Burghaus P.A., Holder A.A. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol. Biochem. Par. 64:1994;165-169.
12. Somner EA, Ogun SA, Sinha KA, Spencer Valero LM, Lee JJ, Harrison JA, Holder AA, Hormaeche CE, Khan CM. Expression of disulphide-bridge-dependent conformational epitopes and immunogenicity of the carboxy-terminal 19 kDa domain of Plasmodium yoelii merozoite surface protein-1 in live attenuated Salmonella vaccina strains. Microbiology 1999;145(1):221-229.
13. Bathurst I.C. Protein expression in yeast as an approach to production of recombinant malaria antigens. Am. J. Trop. Med. Hyg. 50:1994;20-26.
14. Milek R.L.B., De Vries A.A.F., Roeffen W.F.G., Rottier P.J.M., Konings R.N.H. Vaccinia virus for the heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 of the human malaria parasite Plasmodium falciparum. Exp. Par. 90:1998;165-174.
15. Kozak M. The scanning model for translation: An update. J. Cell Biol. 108:1989;229-241.
16. Majumder K. Ligation-free gene synthesis by PCR: synthesis and mutagenesis at multiple loci of a chimeric gene encoding OmpA signal peptide and hirudin. Gene. 110:1992;89-94.
17. Barnes W.M. PCR amplification of up to 35 kb DNA with high fidelity and high yield from bacteriophage templates. Proc. Natl. Acad. Sci. USA. 91:1994;2216-2220.
18. Suggs SV et al. ICN-UCLA Symp Mol Cell Biol, 1981.
19. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current protocols in molecular biology, Massachusetts General Hospital, Harvard Medical School. 1995;John Wiley and Sons, New York.
20. Verbakel JMA. Heterologous gene expression in the yeast Saccharomyces cerevisiae. Thesis of the University of Utrecht, 1991.
21. In Vitrogen® Pichia Expression Instruction Manual, Version 2.0.
22. White C.E., Kempi N.M., Komives E.A. Expression of highly disulfide-bonded proteins in Pichia pastoris. Structure. 15:1994;1003-1005.
23. Zonneveld B.J.M. Cheap and simple yeast media. J. Microbiol. Meth. 4:1986;287-291.
24. Harlow E., Lane D. Antibodies, a laboratory manual. 1988;Cold Spring Harbor Laboratory, New York.
25. Schmitt M.E., Brown T.A., Trunpower B.L. A rapid and simple method for preparation of RNA from Saccharomyces cerevisiae. Nucl. Acids Res. 18:1990;3091-3092.
26. Milek R.L.B., Roeffen W.G., Kocken C.H.M., Jansen J., Kaan A.M., Eling W.M.C., Sauerwein R.W., Konings R.N.H. Immunological properties of recombinant proteins of the transmission-blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. Par. Imm. 20:1998;377-385.
27. Vermeulen A.N., Ponnudurai T., Beckers P.J.A., Verhave J.P., Smits M.A., Meeuwissen J.H.E.T. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J. Exp. Med. 162:1985;1460-1476.
28. Mahuran D., Clements P., Carrella M., Strasberg P.M. A high recovery method for concentrating microgram quantities of protein from large volumes of solution. Annal. Biochem. 129:1983;513-516.
29. Dalsgaard K. A study of the isolation and characterization of the saponin Quil A. Evaluation of its adjuvant activity, with special reference to the vaccination of cattle against foot-and-mouth disease. Act. Vet. Scand. 69:(Suppl.):1978;7-40.
30. Roeffen W., Lensen T., Mulder L., Teelen K., Sauerwein R., van Druten J., Eling W., Meeuwissen J.H.E.Th, Beckers P.J.A. Pfs48/45 competition ELISA detected Plasmodium falciparum transmission-blocking activity in human sera. Am. J. Trop. Med. Hyg. 52:1995;60-65.
31. Roeffen W., Beckers P.J.A., Teelen K., Lensen T., Sauerwein R.W., Meeuwissen J.H.E.Th, Eling W. Plasmodium falciparum: A comparison of the activity of Pfs230-specific antibodies in an assay of transmission blocking immunity and specific competition ELISAs. Exp. Par. 80:1995;15-26.
32. Ponnudurai T., Lensen A.H.W., Van Gemert G.J.A., Bensink M.P.E., Bolmer M., Meeuwissen J.H.E.Th. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Paras. 98:1989;165-173.
33. Romanos M.A., Makoff A.J., Fairweather N.F., Beesley K.M., Slater D.E., Rayment F.B., Payne M.M., Clare J.J. Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA. Nucl. Acids Res. 19:1991;1461-1467.
34. Romanos M.A., Scorer C.A., Clare J.J. Foreign gene expression in yeast: a review. Yeast. 8:1992;423-488.
35. Flaman J.-M., Frebourg T., Moreau V., Charbonnier F., Martin C., Ishioka C., Friend S.H., Iggo R. A rapid PCR fidelity assay. Nucl. Acids Res. 22:1994;3259-3260.
36. Hengen P.N. Fidelity of DNA polymerases for PCR. Trends in Biochem. Sci. 20:1995;324-325.
37. Engels J.W., Uhlmann E. Angew. Chem. Int. Ed. Engl. 28:1989;716-734.
38. Pötgens AJ. Vascular permeability factor, a key regulator of endothelial cell function and tumour angiogenesis. Thesis of the University of Nijmegen, 1995.
39. Kocken C.H.M., Thomas A.W. Rapid screening and mapping of conformational epitopes expressed in the secretion expression system Pichia pastoris. Anal. Biochem. 239:1996;111-112.
40. Steven B., Sherman F. mRNA structures influencing translation in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. 8:1988;1591-1601.
41. Francis A. The influence of 5′ secondary structures upon ribosome binding to mRNA during translation in yeast. J. Biol. Chem. 268:1993;26522-26530.
42. Oliveira C.C., van den Heuvel J.J., McCarthy J.E.G. Inhibition of translation initiation in Saccharomyces cerevisiae by secondary structure: the role of the stability and postition of stem-loops in the mRNA leader. Mol. Micr. 6:1993;521-532.
43. Bennetzen J.L., Hall B.D. Codon selection in yeast. J. Biol. Chem. 257:1981;3026-3031.
44. Chang S.P. Expression systems that best mimic native structure: which ones to try first and why. American Journal of Tropical Medicine and Hygiene. 50:1994;11-19.
45. Weisz O.A., Swift A.M., Machamer C.E. Oligomerization of a membrane protein correlates with its retention in the Golgi Complex. J. Cell. Biol. 122:1993;1185-1196.
46. Majumder K. Ligation-free gene synthesis by PCR: synthesis and mutagenesis at multiple loci of a chimeric gene encoding OmpA signal peptide and hirudin. Erratum: Gene. 116:1992;115-116.